Howdy Catracho,how are you mate.
I reckon if I was a shareholder in pharma that decided to launch a T/O for Prima in its present state,I would be raising my eyebrows at least,but probably asking more serious questions of the T/O companies strategy.
Admittedly the cash on hand is tempting but at this stage nothing else is, apart from the SP.There is no doubt if it comes good, (personally I have no doubt it will,but then again who am I) it will have seemed like a masterstroke.
Partnerships yes,T/O's no for me.
where to now, page-6
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.055(18.6%) |
Mkt cap ! $504.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $5.795M | 16.26M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 406887 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 244097 | 7 |
View Market Depth
| Last trade - 15.40pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |